Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

Completed · Phase 3

Conditions studied: Asthma

In brief

To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.

Key facts

Study ID

NCT00588406

Run by

Northwell Health

People needed

95

Starts

2007-09-01

Expected to finish

2009-12-01

Last updated by the study team

2016-01-21

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• FEV1<50% predicted after bronchodilator therapy, age 18-60, presenting to an emergency department with acute asthma

You may not qualify if…

• other chronic lung disease, >15 pack years smoking

Where it is running

• Nassau University Medical Center — East Meadow, New York, United States
• Long Island Jewish Medical Center — Queens, New York, United States
• Jacobi Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.